Helwig, Christoph

Merck KGaA, Darmstadt (Germany)

1 paper on CoChatORCID 0000-0003-4916-9918

Most cited papers

Verified
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Strauss, J., Heery, C. R., Schlom, J., Madan, R. A., Cao, L., Kang, Z., Lamping, E., Marté, J. L., Donahue, R. N., Grenga, I., et al. (2018) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 406

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free